Eurofins, FR0014000MR3

Eurofins stock: H1 adjusted margin expands 130.00 basis points

Published on 10/20/2026 at 15:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eurofins targets 24.00 percent margin in 2027. Eurofins stock costs EUR 79.24 on October 20, 2026, up 0.99 percent versus Tradegate close.

H1 margin and trading price

  • Eurofins reported 130.00 basis points of adjusted EBITDA margin expansion for the first half of 2026 on July 23, 2026.
  • Adjusted earnings per share grew 29.00 percent in the first half of 2026.
  • Eurofins stock costs EUR 79.24 at Lang & Schwarz on October 20, 2026 at 3:32 p.m. CEST, 0.99 percent above the Tradegate close of October 19, 2026.
Isometrische 3D-Darstellung der Testprozesskette zeigt die Wertschöpfung von Eurofins Scientific SE, ISIN FR0014000MR3, im Labor, Illustration mit AI erstellt.

Eurofins reported a 130.00-basis-point expansion in its adjusted EBITDA margin for the first half of 2026, while adjusted earnings per share grew 29.00 percent. The company published those results on July 23, 2026, according to Eurofins. At Lang & Schwarz, the stock was trading at EUR 79.24 on October 20, 2026 at 3:32 p.m. CEST, 0.99 percent above the Tradegate close of October 19, 2026 at EUR 78.46.

Margin gains sharpen the earnings picture

The first-half improvement gives Eurofins a stronger operating base heading into the second half of 2026. The company said adjusted EBITDA margin expansion reached 130.00 basis points, while adjusted earnings per share increased 29.00 percent over the same reporting period. Those figures point to faster profit growth than the headline margin movement alone suggests.

The 2027 margin target

Eurofins maintains an adjusted EBITDA margin objective of 24.00 percent for fiscal year 2027, alongside a long-term average revenue growth objective of 6.50 percent per year. The objectives are part of the company investor materials dated July 23, 2026, which also describe continuing investment in laboratory networks and digital systems.

Price position and valuation

The euro quotation is only 0.78 above the Tradegate close used for the daily comparison, leaving the session change below the 1.00-percent threshold for a directional headline. The finance quote for Eurofins on October 20, 2026 showed a market capitalization of EUR 13.7 billion, a price-to-earnings ratio of 27.49, and a 52-week range of EUR 54.86 to EUR 79.22.

Dates investors can track

Eurofins has scheduled its nine-month 2026 trading update before the market opens on October 21, 2026, with a conference call at 3:00 p.m. CEST, according to Eurofins. The company also plans an investor event in Amersfoort on October 23, 2026. That schedule puts the next operating update immediately ahead of the market's assessment of the margin trajectory.

Stock stays near its yearly high

Eurofins combines a dated 2026 earnings improvement with a share price near the top of its reported yearly range. The next company update will provide the next quantified test of whether margin expansion is continuing.

The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.

Eurofins stock at a glance

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: ERF
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz (as of October 20, 2026, 3:32 p.m. CEST): EUR 79.24
  • Change versus Tradegate close: plus 0.99 percent
  • Tradegate close (October 19, 2026): EUR 78.46
  • Market capitalization: EUR 13.7 billion (as of October 20, 2026)
  • 52-week range: EUR 54.86-79.22 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Market context: Market report CAC 40.

More news and analyses on Eurofins stock

Disclaimer...
en | FR0014000MR3 | EUROFINS | boerse | 70374258 | bgmi